LSA
OCUL icon

Leonteq Securities AG’s Ocular Therapeutix OCUL Stock Holding History

Leonteq Securities AG’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,000
Closed -$232K – 1361
2025
Q2 		$232K Buy
+25,000
New +$196K 0.01% 539
2022
Q4 		– Sell
-13,000
Closed -$54K – 1336
2022
Q3 		$54K Hold
13,000
– – ﹤0.01% 790
2022
Q2 		$52.3K Buy
13,000
+6,000
+86% +$22.7K ﹤0.01% 819
2022
Q1 		$34.6K Buy
+7,000
New +$38.8K ﹤0.01% 936
2021
Q3 		– Sell
-2,000
Closed -$28.4K – 1193
2021
Q2 		$28.4K Buy
2,000
+1,000
+100% +$15.2K ﹤0.01% 905
2021
Q1 		$16.4K Buy
+1,000
New +$19.3K ﹤0.01% 904

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Leonteq Securities AG's OCUL Position: Q3 2025 in Review

Leonteq Securities AG sold out of Ocular Therapeutix (OCUL) in Q3 2025, closing a stake of 25,000 shares — an estimated $232K sold.

Leonteq Securities AG first reported a position in OCUL in Q1 2021 and held it in 6 quarters. The position peaked at $232K in Q2 2025. 216 funds tracked by Wall St. Rank hold OCUL as of Q3 2025.

  • Leonteq Securities AG reported no remaining Ocular Therapeutix position as of Q3 2025 after selling out during the quarter.
  • Leonteq Securities AG sold 25,000 Ocular Therapeutix shares in Q3 2025, an estimated $232K.
  • Leonteq Securities AG first reported a position in Ocular Therapeutix in Q1 2021 and held it in 6 quarters.
  • Leonteq Securities AG's Ocular Therapeutix position peaked at $232K in Q2 2025.
  • 216 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2025.

Based on Leonteq Securities AG's 13F filing for Q3 2025, filed 17 Feb 2026.